在挑战阶段释放的IL-33以年龄相关的方式调节过敏性喘
Hangyu Liu1,2, Min Wu3, Qiangqiang Wang1
1Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cellular & molecular immunology
|August 12, 2024
概括
介素-33 (IL-33) 在新生儿过敏喘发育中起着关键作用,但随着年龄的增长,其影响会减弱. 年龄显著影响IL-33.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 过敏研究 研究过敏
背景情况:
- 2型警示素,包括IL-33,是2型炎症的关键媒介.
- IL-33与过敏性喘有很强的联系,特别是在儿童中.
- 对于IL-33在过敏性喘发展中的年龄特异性作用尚不清楚.
研究的目的:
- 调查IL-33在过敏性喘发展中的年龄相关作用.
- 为了比较IL-33缺乏对新生儿和成年小鼠过敏喘的影响.
主要方法:
- 在新生儿和成年小鼠中使用了卵胺 (OVA) 诱导的过敏喘模型.
- 评估IL-33/ST2缺乏对先天性淋巴细胞 (ILC2) 和T助手2 (Th2) 细胞反应的影响.
- 研究了补偿机制以及其他警示素和细胞类型的作用.
主要成果:
- IL-33是新生儿肺部中占主导地位的警示剂,其缺乏可以消除过敏喘的发展.
- 在两年龄组中,IL-33/ST2缺乏同样降低了ILC2反应,但仅在新生儿中阻止了Th2反应.
- 在成年小鼠中,IL-33/ST2缺乏导致补偿TSLP产生,增强Th2反应.
- 新生儿中富含的 γδ T17 细胞抑制了警示素,可能抑制喘.
结论:
- 在过敏性喘期间IL-33在ILC2和Th2反应中的作用取决于年龄.
- 在制定过敏性喘干预措施时,年龄是需要考虑的关键因素.
相关概念视频
01:20Asthma: Pathogenesis and Management
378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
02:06Allergic Reactions
27.3K
Overview
27.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K